Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Acta Neuropathologica
|
April 10, 2010
Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord
Heiko Braak, Albert Ludolph, Dietmar R Thal, et al.
Journal of Neurology
|
March 6, 2025
The deltoid muscle and the pattern of paresis in ALS
Albert Ludolph, Veronika Klose, Jens Dreyhaupt, et al.
Frontiers in Psychology
|
July 30, 2014
Well-being in amyotrophic lateral sclerosis: a pilot experience sampling study
Ruben G L Real, Thorsten Dickhaus, Albert Ludolph, et al.
Nature Reviews. Neurology
|
July 27, 2023
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert Ludolph, Luc Dupuis, Edward Kasarskis, et al.
Brain : a Journal of Neurology
|
November 26, 2008
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
Gilbert Bensimon, Albert Ludolph, Yves Agid, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report
Sarah Jesse, Jan Philipp Delling, Michael Schön, et al.
Experimental Neurology
|
June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS
Hans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Neuroepidemiology
|
June 13, 2024
Motor Neuron Disease Population-Based Registry in Egypt: Where Do We Stand?
Nabila Hamdi, Omnia Ocab, Radwa Soliman, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
November 20, 2009
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial
Vincent Meininger, Vivian E Drory, P Nigel Leigh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 30, 2015
A revision of the El Escorial criteria - 2015
Albert Ludolph, Vivian Drory, Orla Hardiman, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Acta Neuropathologica
|
April 10, 2010
Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord
Heiko Braak, Albert Ludolph, Dietmar R Thal, et al.
Journal of Neurology
|
March 6, 2025
The deltoid muscle and the pattern of paresis in ALS
Albert Ludolph, Veronika Klose, Jens Dreyhaupt, et al.
Frontiers in Psychology
|
July 30, 2014
Well-being in amyotrophic lateral sclerosis: a pilot experience sampling study
Ruben G L Real, Thorsten Dickhaus, Albert Ludolph, et al.
Nature Reviews. Neurology
|
July 27, 2023
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert Ludolph, Luc Dupuis, Edward Kasarskis, et al.
Brain : a Journal of Neurology
|
November 26, 2008
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
Gilbert Bensimon, Albert Ludolph, Yves Agid, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report
Sarah Jesse, Jan Philipp Delling, Michael Schön, et al.
Experimental Neurology
|
June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS
Hans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Neuroepidemiology
|
June 13, 2024
Motor Neuron Disease Population-Based Registry in Egypt: Where Do We Stand?
Nabila Hamdi, Omnia Ocab, Radwa Soliman, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
November 20, 2009
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial
Vincent Meininger, Vivian E Drory, P Nigel Leigh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 30, 2015
A revision of the El Escorial criteria - 2015
Albert Ludolph, Vivian Drory, Orla Hardiman, et al.
Page
of 12